Association study of gene polymorphisms and depression with abnormal humor in traditional Uighur medicine

BMC Complementary and Alternative Medicine

Halmurat Upur¹  Ayimgul Abla¹  Hanzohra Upur¹  Abdiryim Yusup¹ 

[1] Collage of Traditional Uighur Medicine, Xinjiang Medical University, Xinyi Road 393, Urumqi, China

关键词: 5-HT_1A;    BDNF;    5-HT_2A;    Depression;    Traditional Uighur medicine;   

Others  :  1220498
DOI  :  10.1186/1472-6882-13-332

 received in 2013-06-03, accepted in 2013-11-21,  发布年份 2013

【 摘 要 】

Background

According to the humor theory of Traditional Uighur Medicine (TUM), a same disease is classified into different abnormal humor types and corresponding methods are applied to treat the diseases according to the type of abnormal humor characteristics. To date the biological foundation of classification of diseases by humor theory has been little studied and the mechanism of action is still unclear. In the present study, we aimed to investigate the association between some related gene polymorphisms and depression with abnormal humor in TUM.

Methods

201 cases of depression patients in a Uighur population were divided into two groups as: 107 cases of depression patients with abnormal black bile (ABB), 94 cases of depression patients with none abnormal black bile (nABB), and 50 healthy people were served as control group. Venous blood was used to isolate DNA samples, and the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used for genotyping of single nucleotide polymorphisms (SNPs). Polymorphisms in the serotonin 2A (5-HT_2A) receptor gene, brain derived neurotrophic factor (BDNF), serotonin 1A (5-HT_1A) receptor gene were investigated in each groups, respectively.

Results

The 5-HT_2A A-1438G, 5-HT_2A T102C, BDNF Val66Met, and 5-HT_1A C-1019G gene polymorphisms showed significant association with ABB. However, no difference between nABB and controls was found for those genotype distribution and allele frequency. Moreover, the T102C and A1438G SNPs in the 5-HT_2A receptor gene polymorphisms were in linkage disequilibrium. In addition, the OR associated with the combination of Val66Met-Val/Val genotype plus the presence of -1019C allele was 8.393 for ABB compared with controls (OR 8.393; 95% CI 1.807 ~ 38.991; P= 0.003). Moreover, the OR associated with the presence of -Met plus -1019C alleles was 12.194 for ABB compared with controls (OR 12.194; 95% CI 1.433 ~ 103.776; P= 0.005). The OR associated with the presence of -1438C/C plus Val/Val genotypes was 7.738 for ABB compared with controls (OR 7.738; 95% CI 1.566 ~ 38.241; P= 0.005).

Conclusion

It was concluded that there were significant relationship between the gene polymorphisms and classification of depression with abnormal humor in TUM. The 5-HT_2A A-1438G, 5-HT_2A T102C, BDNF Val66Met, and 5-HT_1A C-1019G gene polymorphisms might predict the incidence of depression with ABB.

【 授权许可】

   
2013 Yusup et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S: Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004, 184:393-403.
• [2]Insel TR, Charney DS: Research on major depression: strategies and priorities. JAMA 2003, 289(23):3167-3168.
• [3]Krishnan V, Nestler EJ: The molecular neurobiology of depression. Nature 2008, 455(7215):894-902.
• [4]Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58(3):175-189.
• [5]Krishnan V, Nestler EJ: Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 2010, 167(11):1305-1320.
• [6]Arikha N: Passions and Tempers: A History of Humor. New York: Harper Collins Publishers; 2007:10.
• [7]Wong ML, Licinio J: Research and treatment approaches to depression. Nat Rev Neurosci 2001, 2(5):343-351.
• [8]Miller G: Psychiatry. Beyond DSM: seeking a brain-based classification of mental illness. Science 2010, 327(5972):1437.
• [9]Avicenna (adapted by Laleh Bakhtiar): Canon of Medicine (al-Qanun fi al-tibb), Volume I. Chicago: Great Books of the Islamic World, Kazi Publications; 1999.
• [10]Upur H, Yusup A, Umar A, Moore N: Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. Therapie 2004, 59(4):483-484.
• [11]Upur H, Yusup A: New Conception on the Theory of Abnormal Black Bile in Traditional Uighur Medicine. Urumqi, China: Xinjiang Science and Technology Press; 2009.
• [12]Upur H, Yusup A: Theory of Mizaj and Hilit in Uighur Medicine and Modern Study. Urumqi, China: Xinjiang Science and Technology Press; 2003.
• [13]Dai W, Renagul A, Upur H, Peng X: Study of serotonin transporter gene polymorphisms in disease of patients with abnormal black Savda. Wei Sheng Yan Jiu 2009, 38:265-269.
• [14]Renaguli A, Meryemgul M, Yusup A: Study on the correlation between pre-thrombotic biomarkers and traditional Uyghur medicinal syndromes of malignant tumor. Chin J Integr Med 2011, 31:346-349.
• [15]Yin P: Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 871:322-327.
• [16]Christiansen L, Tan Q, Iachina M, Bathum L, Kruse TA, McGue M, Christensen K: Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biol Psychiatry 2007, 61(2):223-230.
• [17]Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS: Serotonin receptor 2A gene polymorphism (−1438A/G) and short-term treatment response to citalopram. Neuropsychobiology 2005, 52(3):155-162.
• [18]Hong CJ, Chen TJ, Yu YW, Tsai SJ: Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006, 6(1):27-33.
• [19]Kato M, Fukuda T, Wakeno M, Fukuda K, Okugawa G, Ikenaga Y, Yamashita M, Takekita Y, Nobuhara K, Azuma J, Kinoshita T: Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 2006, 53(4):186-195.
• [20]McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, et al.: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78(5):804-814.
• [21]Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, et al.: Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003, 23(25):8788-8799.
• [22]Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, van Heertum RL, Arango V, Mann JJ: Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006, 59(2):106-113.
• [23]Chao MV, Rajagopal R, Lee FS: Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006, 110(2):167-173.
• [24]Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004, 5(1):11-25.
• [25]Yulug B, Ozan E, Kilic E: Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. J Neuropsychiatry Clin Neurosci 2010, 22(1):123. E125-126
• [26]Micheli D, Bonvicini C, Rocchi A, Ceravolo R, Mancuso M, Tognoni G, Gennarelli M, Siciliano G, Murri L: No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease. J Alzheimers Dis 2006, 10(4):371-378.
• [27]Cheng CY, Hong CJ, Yu YW, Chen TJ, Wu HC, Tsai SJ: Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res 2005, 140(1–2):86-90.
• [28]Dinacci D, Tessitore A, Russo A, de Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, et al.: BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol Sci 2011, 32(1):117-123.
• [29]Choi WS, Lee BH, Yang JC, Kim YK: Association Study between 5-HT1A Receptor Gene C(−1019)G Polymorphism and Panic Disorder in a Korean Population. Psychiatry Investig 2010, 7(2):141-146.
• [30]Li D, Duan Y, He L: Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006, 340(3):1006-1015.
• [31]Correa H, de Marco L, Boson W, Viana MM, Lima VF, Campi-Azevedo AC, Noronha JC, Guatimosim C, Romano-Silva MA: Analysis of T102C 5HT2A polymorphism in Brazilian psychiatric inpatients: relationship with suicidal behavior. Cell Mol Neurobiol 2002, 22(5–6):813-817.
• [32]Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B: Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 2001, 303(2):119-122.
• [33]Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K: Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J Psychiatr Res 2001, 35(3):173-176.
• [34]Yoon HK, Yang JC, Lee HJ, Kim YK: The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 2008, 22(8):1529-1534.
• [35]Khait VD, Huang YY, Zalsman G, Oquendo MA, Brent DA, Harkavy-Friedman JM, Mann JJ: Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 2005, 30(1):166-172.
• [36]Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59(12):1116-1127.
• [37]Kato M, Serretti A: Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 2010, 15(5):473-500.
• [38]Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B: Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010, 15(3):260-271.
• [39]Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, Day IN, Ebrahim S, Smith GD, Shugart YY: Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(6):814-821.
• [40]Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM: The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006, 27(12):1834-1837.
• [41]Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH: BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005, 30(7):1353-1361.
• [42]Oswald P, Del-Favero J, Massat I, Souery D, Claes S, van Broeckhoven C, Mendlewicz J: No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol 2005, 15(5):491-495.
• [43]Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmal C, Hofels S, et al.: Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005, 58(4):307-314.
• [44]Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 2003, 123B(1):19-22.
• [45]Shimizu E, Hashimoto K, Iyo M: Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004, 126B(1):122-123.
• [46]Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24(45):10099-10102.
• [47]Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, et al.: Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005, 10(7):631-636.
• [48]Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736.
• [49]Lu B, Pang PT, Woo NH: The yin and yang of neurotrophin action. Nat Rev Neurosci 2005, 6(8):603-614.
• [50]Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimaki T: Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm 2007, 114(8):1065-1068.